Conformation-Stabilized GPCRs for Pathway Specific Drug Discovery
Recent groundbreaking advances lead to a "GPCR" Nobel Prize in 2012 and have rendered many commonly employed GPCR drug discovery technologies obsolete. We want to be part of the next generation of GPCR discovery by developing technologies that define, and then lock single stabilized GPCR conformational states for both physical drug discovery and for in silico drug discovery. We will deliver disruptive physical and computational products and services based on these technologies.
2 368 600.00€
Biology / Biotechnology
Other Biotechnology / Molecular technology